Since synergistic effects of CXCL12 and CXCL11 on tumor cell migration do not correlate with the selective use of distinct chemokine receptors / receptor combinations, we asked whether additive effects would correlate with receptor-activated signaling pathways. This evidence concerns the gene CXCL12 and neoplasm.